Carrie Kefalas
About Carrie Kefalas
Carrie Kefalas is a Clinical Trial Lead in Immuno-Oncology at Bristol-Myers Squibb, with extensive experience in oncology clinical compliance and pharmacovigilance.
Title
Carrie Kefalas holds the position of Clinical Trial Lead in Immuno-Oncology within Oncology Clinical Development. She is currently based in Princeton, New Jersey, United States.
Current Role at Bristol-Myers Squibb
Carrie Kefalas is currently employed at Bristol-Myers Squibb as a Clinical Trial Lead in Immuno-Oncology, focusing on oncology clinical development. Her responsibilities include overseeing and managing clinical trials, ensuring compliance with industry standards, and contributing to the advancement of oncology treatments.
Previous Experience at Bristol-Myers Squibb
Carrie Kefalas previously worked at Bristol-Myers Squibb as a Medical Director and Medical Safety Assessment Physician within the Global Pharmacovigilance and Epidemiology department. She held this position from 2013 to 2017 in New York, New York. Her role involved overseeing global safety assessments, contributing to pharmacovigilance activities, and ensuring patient safety in clinical trials.
Experience at Merck
Carrie Kefalas gained experience in clinical risk management during her tenure at Merck. She served as a Clinical Risk Management Physician from 2012 to 2013, where she managed clinical risks and contributed to the development of safety protocols for clinical trials.
Education and Training
Carrie Kefalas holds a Doctor of Medicine degree from Southern Illinois University School of Medicine, which she completed between 2005 and 2009. She furthered her education with a Master of Public Health from the University of Kentucky, obtained from 2010 to 2012. Her training also includes a residency at the University of Kentucky from 2010 to 2011, followed by a role as Chief Resident Physician from 2011 to 2012.